由非编码RNA编码的小酸在瘤入侵和迁移中的作用
Jie Liu1,2, Xiyue Chang1,2, Laeeqa Manji1
1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in pharmacology
|October 1, 2024
概括
由非编码RNA (SPEN) 编码的小在恶性瘤发育中至关重要. 了解SPEN机制为癌症入侵和迁移提供了新的治疗点,改善了患者的预后.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 传统上被认为非蛋白质编码的非编码RNA (ncRNA) 越来越多地被认为具有调节作用.
- 新兴证据突出显示,在关键的细胞过程中,ncRNAs (SPENs) 编码的小.
- SPENs与恶性瘤的发展和进展有关.
研究的目的:
- 审查SPENs在瘤入侵和迁移中的机制.
- 探索SPENs作为癌症诊断生物标志物和治疗点的潜力.
- 提供对抗癌症转移的新策略的见解.
主要方法:
- 关于SPEN及其在癌症中的作用的最新研究的文献综述.
- 对SPEN参与瘤细胞过程的分子机制的分析.
- 在癌症诊断和治疗的背景下对SPENs的当前知识的综合.
主要成果:
- SPENs调节关键的细胞过程,包括骨重组,细胞间粘附和信号通路.
- 这些SPEN显著影响恶性瘤细胞的入侵和迁移能力.
- SPENs显示出作为癌症早期检测的生物标志物和新型治疗的标的潜力.
结论:
- SPENs在促进瘤入侵和迁移方面发挥着关键作用,有助于癌症预后不佳.
- 准SPEN是开发更有效的癌症治疗方法的一个有希望的途径.
- 对SPEN的进一步研究可以导致癌症诊断和治疗策略的进步.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
2.6K
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
